RxDoctor Payments Data

Kenneth Binmoeller, MD

Gastroenterology · San Francisco, CANPI 1851321715

Payments from drug & device makers

What this record shows

This record is dominated by ownership interests: $378,996 of the $507,242 with a category attached, or 74.7%. Boston Scientific accounts for 85.7% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $440,012 and has fallen 90.4% since, to $42,225 in 2025. Among gastroenterology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$507,242in general payments, 2019–2025

Across 91 payments — averaging $5574.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$435K
  • Micro-tech Endoscopy USA, Inc.$59K
  • Olympus Corporation$9K
  • Cook Medical LLC$4K
  • Olympus America Inc.$274
  • Medtronic$250
  • plus $627 from 6 others

What the payments were for

  • Royalty or licence$51,23110%
  • Consulting fees$15,0003%
  • Speaking & faculty fees$24,8005%
  • Grants$8,0002%
  • Travel & lodging$15,5373%
  • Food & beverage$4,8691%
  • Education$8,7552%
  • Gifts$530%
  • Ownership interest$378,99675%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$507,242 in reported general payments places this provider in the 95th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California →

Medicare billing

Part B allowed, 2024
$143,938
Medicare patients
274
Services billed
718

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in San Francisco

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →